Nuvation Bio
NUVB
NUVB
220 hedge funds and large institutions have $1.89B invested in Nuvation Bio in 2025 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 70 increasing their positions, 70 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
8% more funds holding
Funds holding: 203 → 220 (+17)
0% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 70
2.82% less ownership
Funds ownership: 64.44% → 61.62% (-2.8%)
Holders
220
Holding in Top 10
9
Calls
$36.6M
Puts
$10.5M
Top Buyers
| 1 | +$19.7M | |
| 2 | +$15M | |
| 3 | +$9.84M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$7.93M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$6.34M |
Top Sellers
| 1 | -$25.6M | |
| 2 | -$13.4M | |
| 3 | -$11.5M | |
| 4 |
Jane Street
New York
|
-$11.1M |
| 5 |
ACM
Aisling Capital Management
New York
|
-$11M |
